1-3 of 3
Agnes S. Yong
Close
Sort by
Journal Articles

Enhanced Natural Killer and Cytotoxic T Lymphocyte Responses, with Decreased Monocytic Myeloid Derived Suppressor Cells May Promote Treatment Free Remission in Chronic Myeloid Leukaemia Patients Following Tyrosine Kinase Inhibitor Cessation

Amy Hughes, PhD, Jade Clarson, B.Sc, Deborah L White, PhD FFSc (RCPA), David M. Ross, MBBS, PhD FRACP, FRCPA, Timothy P. Hughes, MD FRACP, FRCPA, MBBS, FAAHMS, Agnes S Yong, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1122.
https://doi.org/10.1182/blood.V128.22.1122.1122
Published: 2016
Journal Articles

KIR2DL5B genotype predicts outcomes in CML patients treated with response-directed sequential imatinib/nilotinib strategy

Clinical Trials & Observations Brief Report
David T. Yeung, Carine Tang, Ljiljana Vidovic, Deborah L. White, Susan Branford, Timothy P. Hughes, Agnes S. Yong
Journal: Blood
Blood (2015) 126 (25): 2720–2723.
https://doi.org/10.1182/blood-2015-07-655589
Published: 2015
Includes: Supplemental data
Journal Articles

Chronic Myeloid Leukemia Patients with Deep Molecular Responses to Tyrosine Kinase Inhibitors Have Increased Effector Natural Killer and Cytotoxic T Cell Immune Responses to Leukaemia-Associated Antigens and Concomitant Reduced Immune Suppressors

Amy Hughes, B.Sc (hons), PhD, Carine Tang, B.Sc (hons), PhD, Jade Clarson, B.Sc, Ljiljana Vidovic, Animal Sc (hons), Timothy P. Hughes, MD MBBS, FRACP, FRCPA, Agnes S Yong, MD PhD
Journal: Blood
Blood (2015) 126 (23): 18.
https://doi.org/10.1182/blood.V126.23.18.18
Published: 2015